This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...
Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results